Organigram to Report First Quarter Fiscal 2021 Results on January 12, 2021

Rhea-AI Summary

Organigram Holdings Inc. (NASDAQ: OGI) will release its first quarter Fiscal 2021 earnings results on January 12, 2021. The results cover the period ending November 30, 2020. Following the report, a conference call will take place at 8:00 AM Eastern Time to discuss the details. Interested parties can register for the call via the provided link. Organigram, a leading cannabis producer based in New Brunswick, Canada, focuses on high-quality indoor-grown cannabis, serving both medical and recreational markets while exploring international partnerships.

Positive

• Scheduled release of Q1 Fiscal 2021 earnings results may provide insights into company performance.
• Growing international business partnerships could enhance future revenue opportunities.

Negative

• None.

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter Fiscal 2021 ended November 30, 2020 on Tuesday January 12, 2021 before market open.

The Company will host a conference call to discuss the results:

Date:					January 12, 2021
Time:					8:00am Eastern Time

To register for the conference call, please use this link: http://www.directeventreg.com/registration/event/8296223

To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of the call. After registering, a confirmation will be sent through email, including dial in details and unique conference call codes for entry. Registration is open through the live call.

To access the webcast: https://event.on24.com/wcc/r/2948477/717095EA7CC7536A80638510D69CD46A

A replay of the webcast will be available within 24 hours after the conclusion of the call at https://www.organigram.ca/investors and will be archived for a period of 90 days following the call.

About Organigram Holdings Inc.

Organigram Holdings Inc. is a NASDAQ Global Select and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. 

Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company's global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, SHRED and Trailblazer. Organigram's facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).

This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include changes in scheduling, factors and risks as disclosed in the Company’s most recent annual information form, management’s discussion and analysis and other Company documents filed from time to time on SEDAR (see www.sedar.com) and filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210104005161/en/

FAQ

When will Organigram report its first quarter Fiscal 2021 earnings results?

Organigram will report its first quarter Fiscal 2021 earnings results on January 12, 2021.

What time is the Organigram conference call scheduled for?

The conference call is scheduled for 8:00 AM Eastern Time on January 12, 2021.

How can I register for the Organigram earnings conference call?

You can register for the earnings conference call through the provided registration link.

What does Organigram focus on in its business operations?

Organigram focuses on producing high-quality, indoor-grown cannabis for medical and recreational markets, as well as developing international partnerships.